Subscribe

What are you looking for?

Main Menu

明報新聞網

英矽智能：抑制劑ISM6331獲美FDA授予快速通道資格

Future Wealths
Future Wealths
29 7 月, 2026
One Min Read
1 Views
0 Comments
英矽智能(3696)公布，其自研AI驅動的潛在同類最佳創新泛TEAD抑制劑ISM6331已獲得美國食品藥品監督管理局(FDA)授予的快速通道資格(FTD)，用於治療既往接受過抗PD-1抗體治療（無論是否聯合抗CTLA-4抗體治療）及含鉑化療後疾病進展的、不可切除惡性胸膜間皮瘤成年患者。

原文: https://finance.mingpao.com/fin/instantf/20260729/1785286291824/%E8%8B%B1%E7%9F%BD%E6%99%BA%E8%83%BD-%E6%8A%91%E5%88%B6%E5%8A%91ism6331%E7%8D%B2%E7%BE%8Efda%E6%8E%88%E4%BA%88%E5%BF%AB%E9%80%9F%E9%80%9A%E9%81%93%E8%B3%87%E6%A0%BC%22%20target=%22blank

Last Update: 29 7 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept